Literature DB >> 24565247

Anesthesia for cesarean section in a patient with Guillain-Barre syndrome: Case report.

Daniel Volquind1, Roberto Taboada Fellini2, Giana Lucho Rose2, Gabriel Pedro Tarso3.   

Abstract

BACKGROUND AND OBJECTIVES: Guillain-Barre syndrome during pregnancy is considered a rare neurological complication, and there is no consensus in literature for anesthetic management for cesarean section in such patients. The objective of this paper is to report the case of a pregnant woman with Guillain-Barre syndrome undergoing cesarean section. CASE REPORT: Female patient, 22-year old, 35 weeks and 5 days of gestation, undergoing cesarean section, hospitalized, reporting decreased strength and lower limb paresthesias. Cerebrospinal fluid (CSF) analysis showed increased protein (304 mg.dL(-1)) without increased cellularity. The anesthetic technique used was general anesthesia induced with propofol (1.5 mg.kg(-1)) and maintained with 2% sevoflurane in oxygen and fentanyl (3 μg.kg(-1)). The procedure was uneventful for both mother and neonate. The patient was discharged 10 days after admission, after progressive improvement of neurological symptoms.
CONCLUSION: The anesthetic technique for pregnant women with Guillain-Barre syndrome requiring cesarean section remains at the discretion of the anesthesiologist, who should be guided by the clinical conditions and comorbidities of each patient.
Copyright © 2013 Sociedade Brasileira de Anestesiologia. Published by Elsevier Editora Ltda. All rights reserved.

Entities:  

Keywords:  Anesthesia; Cesarean Section; Guillain-Barre Syndrome; Obstetrical

Mesh:

Year:  2013        PMID: 24565247     DOI: 10.1016/j.bjane.2012.06.002

Source DB:  PubMed          Journal:  Braz J Anesthesiol


  1 in total

1.  A unique case of free-floating gastric band tubing causing intraabdominal sepsis in a patient with locked-in syndrome secondary to Guillain-Barré syndrome.

Authors:  Lina Cadili; Noelle L Davis
Journal:  J Surg Case Rep       Date:  2022-03-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.